Randomized phase III trial: a decision aid in cardiovascular prevention - risk consultation related to absolute and relative risk

ISRCTN ISRCTN71348772
DOI https://doi.org/10.1186/ISRCTN71348772
Secondary identifying numbers N/A
Submission date
17/01/2006
Registration date
02/03/2006
Last edited
24/06/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Norbert Donner-Banzhoff
Scientific

University of Marburg
Department of General Practice and Family Medicine
Robert-Koch-Strasse 5
Marburg
35033
Germany

Phone +49 (0)64 2128 65119
Email norbert@med.uni-marburg.de

Study information

Study designTwo-arm parallel controlled cluster randomized intervention study
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)Not specified
Study typeQuality of life
Scientific titleRandomized phase III trial: a decision aid in cardiovascular prevention - risk consultation related to absolute and relative risk
Study acronymARRIBA
Study objectivesA consultation based on ARRIBA leads to:
1. An improved quality of counselling (patient's perceived assessment scale)
2. Changes in prescribing behaviour based on risk status
Ethics approval(s)Ethical Committee of the University of Marburg, 18/10/2004, ref: 134/04
Health condition(s) or problem(s) studiedCardiovascular disease
Intervention1. Intervention:
a. Advanced training (continuing education) in shared decision-making, risk calculation, risk communication and the use of decision aids
b. Advanced training in ARRIBA (decision aid and consultation)
2. Control:
Controls receive training after termination of the study
Intervention typeOther
Primary outcome measurePatient's attitude towards consultation (patient's perceived assessment scale)
Secondary outcome measures1. GPs: changes in prescribing behaviour and consultation related to risk status
2. Patients: cardiovascular risk status after six months
Overall study start date01/11/2004
Completion date31/10/2006

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants1100
Key inclusion criteria1. Age >18 years
2. Written informed consent
3. Measurement of cholesterol
Key exclusion criteriaInsufficient mental or verbal ability
Date of first enrolment01/11/2004
Date of final enrolment31/10/2006

Locations

Countries of recruitment

  • Germany

Study participating centre

University of Marburg
Marburg
35033
Germany

Sponsor information

University of Marburg, Department of General Practice and Family Medicine (Germany)
University/education

Robert-Koch-Strasse 5
Marburg
35033
Germany

Phone +49 (0)64 2128 65120
Email baum@med.uni-marburg.de
ROR logo "ROR" https://ror.org/01rdrb571

Funders

Funder type

Government

Bundesministerium für Bildung und Forschung
Government organisation / National government
Alternative name(s)
Federal Ministry of Education and Research, BMBF
Location
Germany

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/06/2012 Yes No
Results article results 02/07/2013 Yes No